Bioequivalence of Ruxolitinib 20 mg Tablets in Healthy Participants Under Fasting Conditions.
This research study is for healthy adult volunteers and aims to compare a new version of a medicine called Ruxolitinib (20 mg tablets) with the original. It's called a 'bioequivalence' study, which means scientists want to check if the new version of the medicine acts the same way in your body as the original, particularly when you take it without food. This is a common and important step in developing new medicines to ensure they are just as safe and effective as existing ones. Healthy participants are needed for this type of study because researchers want to see how the medicine acts without any other health conditions affecting the results.
At a glance
What is this study about?
Imagine you have a favourite brand of crisps, and another company releases their own version. You'd want to know if they taste exactly the same and have the same crunch, right? This study is a bit like that, but for medicine. Researchers are looking at a new version of a medication called Ruxolitinib, which is used to treat certain conditions. They want to make sure this new version works just as well and is just as safe as the original.
To do this, they need healthy volunteers – people who don't have any medical conditions. This helps the researchers understand how the medicine acts in a typical, healthy body without other illnesses changing the results. They're specifically checking something called 'bioequivalence,' which means they're looking to see if the new tablet delivers the same amount of medicine to your bloodstream, at the same speed, as the original tablet, especially when taken on an empty stomach.
This kind of study is a very important first step in bringing new medicines to people who need them. By making sure different versions of a medicine work exactly the same way, we can be confident that patients will get the same benefits, no matter which version they are prescribed.
Key takeaways
- This study is testing a new version of a medicine called Ruxolitinib.
- It needs healthy adult volunteers, aged 18 or over.
- The main aim is to check if the new medicine works the same way as the original, especially when taken on an empty stomach.
- Participation involves health checks, taking medication, and regular blood tests.
- You will be closely monitored by medical staff throughout the study.
- Your involvement helps ensure new medicines are safe and effective for patients.
Who may be eligible?
This study is looking for healthy adults, both men and women, aged 18 years and older. You don't need to have any specific medical condition to take part.
Because the study wants to see how the medicine works in a typical healthy person, you wouldn't be able to join if you have any serious or ongoing health problems, or if you are taking certain other medications that could affect the results. Doctors and nurses involved in the study will check your health carefully to make sure it's safe for you to participate.
They will also provide you with a full list of things that might prevent you from joining, such as certain lifestyle choices or past medical history. It's important to be completely honest about your health so that the study is safe for you and the results are accurate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you consider yourself generally healthy with no ongoing medical conditions?
- Are you able to follow specific instructions about food and drink?
- Are you available for regular clinic visits, which might include overnight stays?
- Are you willing to have blood samples taken regularly?
What does participation involve?
If you decide to take part, you would first have a screening visit to check your general health and make sure you're suitable for the study. This would likely involve a health check-up, blood and urine tests.
During the study itself, you would receive doses of the Ruxolitinib medicine (or a comparison version). This would be done under fasting conditions, meaning you would not eat for a set period before and after taking the medicine. You would have several visits to the clinic, possibly including an overnight stay, where blood samples would be taken regularly to measure how your body is handling the medicine.
Between these visits, you'd be asked to follow specific instructions, for example, about what you can eat and drink and what activities to avoid. There would also be follow-up checks to ensure you remain well after completing the study medication. The total duration of your involvement could range from a few weeks to a couple of months, depending on the study design.
Potential risks and benefits
Locations (1)
- —UnverifiedPortugal
Common questions
What is Ruxolitinib?
Ruxolitinib is a medicine used to treat certain blood and bone marrow disorders. In this study, we're looking at a new version of it.
Why do you need healthy volunteers?
We need healthy volunteers so we can understand how the medicine works in a typical, healthy body without other health conditions affecting the results.
What does 'bioequivalence' mean?
It means we're checking if a new version of a medicine acts exactly the same way in your body as the original version – like taking the same amount of medicine at the same speed.
Do I have to take the medicine on an empty stomach?
Yes, part of this study involves taking the medicine under 'fasting conditions,' which means on an empty stomach, to see how it works that way.
Will I be paid for taking part?
Most studies for healthy volunteers offer some payment for your time, travel, and inconvenience. This will be fully explained before you agree to take part.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.